You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日總結》恆指升341點 美團揚逾5% 藥明生物彈逾9%
美債孳息回落,英偉達(NVDA.US)市後公布業績超預期股價升。港股早市上升。恆指高開146點後升幅擴大,半日升341點或1.9%,報18,186點;國指升136點或2.2%,報6,253點;恆生科技指數升128點或3.2%,報4,137點。大市半日成交總額518.95億元,滬、深港通南下交易半日淨流入17.96億及16.48億元人民幣。 科技股領漲,市場繼續憧憬文心一言商業化,百度(09888.HK)抽高5.1%報135元。美團(03690.HK)日內將公布業績,半日股價抽高5.5%報137.5元。阿里(09988.HK)、騰訊(00700.HK)、京東(09618.HK)、網易(09999.HK)、嗶哩嗶哩(09626.HK)及快手(01024.HK)升2.1%至3%。金蝶(00268.HK)及聯想集團(00992.HK)升5%及6.2%,東方甄選(01797.HK)及美圖(01357.HK)升7.8%及8.2%。 市場關注小米造車,小米(01810.HK)升4.3%報12.24元。據報歐洲第二大車廠Stellantis尋求與零跑(09863.HK)合作,零跑炒高12.1%。其他車股方面,吉利(00175.HK)、比亞迪(01211.HK)、長汽(02333.HK)及小鵬(09868.HK)升3%至4.1%。 醫藥股上升。藥明生物(02269.HK)中期收人升18%勝指引,股價抽高9.5%。信達生物(01801.HK)半年虧損收窄至1.39億人幣,股價抽升11.2%。石藥(01093.HK)、百濟神州(06160.HK)及康希諾(06185.HK)升3.2%至4.2%。康龍化成(03759.HK)升6.7%。 消費及內需股造好,呷哺呷哺(00520.HK)及九毛九(09922.HK)升6.1%,名創優品(09896.HK)升5.4%,海底撈(06862.HK)、阿里影業(01060.HK)、貓眼娛樂(01896.HK)、青啤(00168.HK)、潤啤(00291.HK)、康師傅(00322.HK)及攜程(09961.HK)升3.9%至4.7%。濠賭股永利澳門(01128.HK)及美高梅中國(02282.HK)升4.6%及5.1%。 金融股方面,友邦(01299.HK)中期新業務價值實質匯率計按年升32%近預期上限,中期息增至42.29港仙,股價高開2.5%後倒跌,半日跌0.6%報69.55元,國壽(02628.HK)中期淨利潤按年跌8%,股價升1.2%報11.44元。建行(00939.HK)上半年淨利潤按年升3.4%勝預期,股價平收報4.09元。此外,匯控(00005.HK)升0.3%報58.6元,港交所(00388.HK)升3%報289元。 內房股碧桂園(02007.HK)、遠洋(03377.HK)及雅居樂(03383.HK)升3.8%至4.4%,物管股碧服(06098.HK)及雅生活(03319.HK)升6.6%及5%。美元回落,山東黃金(01787.HK)、招金(01818.HK)及中國黃金國際(02099.HK)升6%至6.9%,資源股中鋁(02600.HK)及五礦資源(01208.HK)升5.7%及7.3%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account